Filing Details

Accession Number:
0001127602-14-019258
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-30 18:53:34
Reporting Period:
2014-05-28
Filing Date:
2014-05-30
Accepted Time:
2014-05-30 17:53:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555260 Rebecca Peterson 852 Winter St.
Waltham MA 02451
Svp, Corporate Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-05-28 20,000 $33.72 20,000 No 4 M Direct
Ordinary Shares Disposition 2014-05-28 17,800 $45.79 2,200 No 4 S Direct
Ordinary Shares Disposition 2014-05-28 2,200 $46.47 0 No 4 S Direct
Ordinary Shares Acquisiton 2014-05-28 3,750 $0.00 3,750 No 4 M Direct
Ordinary Shares Disposition 2014-05-28 1,769 $45.74 1,981 No 4 F Direct
Ordinary Shares Disposition 2014-05-30 1,981 $45.87 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2014-05-28 20,000 $0.00 20,000 $33.72
Ordinary Shares Restricted Stock Unit Award Disposition 2014-05-28 3,750 $0.00 3,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,000 2014-05-28 2023-05-28 No 4 M Direct
11,250 2014-05-28 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.39 to $46.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.40 to $46.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. Shares subject to the stock option award vest in four equal annual installments commencing on 5/28/14.
  6. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 5/28/14.